JNJ-2113 achieved all primary and secondary endpoints in the Phase 2b clinical trial FRONTIER 1, including PASI 100 and IGA…
DENVER, CO / ACCESSWIRE / February 7, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company…
Focus on Agency, Client Excellence, Growth, People and Best PracticesBOSTON & NEW YORK--(BUSINESS WIRE)--LaVoieHealthScience (LHS), an integrated investor and public…
VANCOUVER, BC / ACCESSWIRE / February 7, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to…
ATLANTA, GA / ACCESSWIRE / February 7, 2024 / TruLab, a leading provider of sample management solutions, and Florence Healthcare,…
CAMBRIDGE, MA / ACCESSWIRE / February 7, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that Stéphane Bancel, Chief Executive Officer,…
Empowering Our Clients With Advanced SolutionsNEW HYDE PARK, NY / ACCESSWIRE / February 7, 2024 / InfinityRx, a copay program…
Empowering Our Clients With Advanced SolutionsNEW HYDE PARK, NY / ACCESSWIRE / February 7, 2024 / InfinityRx, a copay program…
COLUMBUS, OH / ACCESSWIRE / February 7, 2024 / Today, Two Labs, an Envision Pharma Company and industry leader in…
ALPHARETTA, Ga., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (“Clearside” or the “Company”) (NASDAQ: CLSD), a biopharmaceutical company revolutionizing…